SCHEMBL45609

SCHEMBL45609

O=C(O)c1cc2cc3c4c(c2oc1=O)CCCN4CCC3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 1/20 1.00
USP2 O75604 8/20 0.61
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
ALDH1A1 P00352 5/20 0.61
GAA P10253 4/20 0.61
LMNA P02545 4/20 0.61
KDM4E B2RXH2 4/20 0.61
MAPT P10636 4/20 0.61
TDP1 Q9NUW8 3/20 0.61
RECQL P46063 2/20 0.61
TLR9 Q9NR96 1/20 0.61
CASP1 P29466 6/20 0.57
CASP7 P55210 6/20 0.57
ALOX15 P16050 5/20 0.57
HSD17B10 Q99714 5/20 0.57
BRCA1 P38398 2/20 0.57
HBB P68871 2/20 0.57
HTT P42858 2/20 0.57
ATM Q13315 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29364862 1.00 SLC16A3 (1.00) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL12511762 0.91 SLC16A3 (0.83) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL29413851 0.89 SLC16A3 (0.80) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL21620382 0.89 SLC16A3 (0.80) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL15294904 0.89 SLC16A3 (0.80) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL2843124 0.89 SLC16A3 (0.80) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL10082362 0.89 SLC16A3 (0.80) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL15398172 0.86 SLC16A3 (0.75) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL12761821 0.85 SLC16A3 (0.74) SLC16A3USP2MEN1KMT2AALDH1A1
SCHEMBL13403675 0.85 SLC16A3 (0.74) SLC16A3USP2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1094 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104427-A1 METAL ORGANIC FRAMEWORKS FOR GAS SENSING KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2026-05-21 WO claimed
US-20260133200-A1 RATIOMETRIC FLUORESCENT PROBE FOR DETECTING A COLORECTAL CANCER MARKER HOMOCYSTEINE WITH HIGH SELECTIVITY AND PREPARATION METHOD THEREFOR HUNAN CANCER HOSPITAL (CN) 2026-05-14 US claimed
EP-4624903-A1 LIQUID SPRAY ANALYSIS Rolls-Royce plc (GB) 2025-10-01 EP claimed
US-20250297956-A1 LIQUID SPRAY ANALYSIS ROLLS-ROYCE PLC (GB) 2025-09-25 US claimed
CN-116478173-B Fluorescent probe for monitoring polarity of targeting Golgi apparatus and preparation and application thereof 山西师范大学 2025-03-25 CN claimed
CN-119592028-A Petroleum exploitation tensile cable based on high polymer material and production method thereof 江苏天帝线缆有限公司 2025-03-11 CN claimed
CN-119462680-A Fluorescence probe for detecting sulfur dioxide based on FRET principle and preparation method and application thereof 南京工业大学 2025-02-18 CN claimed
CN-118852214-A Be used for detecting SO2Ratio type fluorescent probe of derivative, and synthetic method and application thereof 泰州学院 2024-10-29 CN claimed
EP-3087312-B1 HEAD-MOUNTED DISPLAY WITH FILTER FUNCTION ESSILOR INT (FR) 2024-09-11 EP claimed
CN-114163432-B Fluorescent probe for detecting ferrous ions with high selectivity and preparation and application thereof 华东理工大学 2024-06-18 CN claimed
CN-115216103-A Functional liquid mulching film with fluorescence effect and mulching film laying method 润涵(山东)生态科技有限公司 2022-10-21 CN claimed
CN-115028759-A Laser manufacturing method based on triplet state up-conversion and application thereof 华中科技大学 2022-09-09 CN claimed
CN-111233880-B Preparation method of hypochlorite fluorescent probe 江苏大学 2022-08-23 CN claimed
EP-2802871-B1 CHARACTERIZATION OF SUBVISIBLE PARTICLES USING A PARTICLE ANALYZER TAKEDA PHARMACEUTICALS CO (JP) 2022-07-27 EP claimed
US-20190018018-A1 SIGNALING CONJUGATES AND METHODS OF USE VENTANA MED SYST INC (US) 2019-01-17 US claimed
US-20180328932-A1 SIGNALING CONJUGATES AND METHODS OF USE VENTANA MED SYST INC (US) 2018-11-15 US claimed
EP-2588443-A2 HAPTEN CONJUGATES FOR TARGET DETECTION Ventana Medical Systems, Inc. (US) 2013-05-08 EP claimed
US-20130109019-A1 HAPTEN CONJUGATES FOR TARGET DETECTION VENTANA MEDICAL SYSTEMS, INC. 2013-05-02 US claimed
WO-2012003476-A2 HAPTEN CONJUGATES FOR TARGET DETECTION VENTANA MEDICAL SYSTEMS, INC. (US) 2012-01-05 WO claimed
EP-0431452-B1 Method for the optical distinction of dental materials and material used in this method IVOCLAR AG (LI) 1994-10-05 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109019-A1 HAPTEN CONJUGATES FOR TARGET DETECTION TYR, TH, TYRO3 SLC16A3 4708/4885USP2 1931/4885MEN1 4775/4885
US-20260133200-A1 RATIOMETRIC FLUORESCENT PROBE FOR DETECTING A COLORECTAL CANCER MARKER HOMOCYSTEINE WITH HIGH SELECTIVITY AND PREPARATION METHOD THEREFOR MTHFD1, DHFR, MTHFD2 SLC16A3 1133/4885USP2 1893/4885MEN1 1236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.